These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19009231)

  • 1. GERD prevalence in migraine patients and the implication for acute migraine treatment.
    Katić BJ; Golden W; Cady RK; Hu XH
    J Headache Pain; 2009 Feb; 10(1):35-43. PubMed ID: 19009231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study.
    Ruszniewski P; Soufflet C; Barthélémy P
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1134-9. PubMed ID: 18671778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective, case-control pilot study of the natural history of pediatric gastroesophageal reflux.
    Young RJ; Lyden E; Ward B; Vanderhoof JA; DiBaise JK
    Dig Dis Sci; 2007 Feb; 52(2):457-62. PubMed ID: 17211703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of gastroesophageal reflux disease in Moscow.
    Bor S; Lazebnik LB; Kitapcioglu G; Manannikof I; Vasiliev Y
    Dis Esophagus; 2016; 29(2):159-65. PubMed ID: 25604401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of gastroesophageal reflux disease in pregnant women.
    Le YT; Luu MN; Mai LH; Hoang AT; Nguyen TT; Quach DT
    Rev Gastroenterol Mex (Engl Ed); 2023; 88(4):341-346. PubMed ID: 35810101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute migraine treatment with oral triptans and NSAIDs in a managed care population.
    Ng-Mak DS; Hu XH; Chen YT; Ma L
    Headache; 2008 Sep; 48(8):1176-85. PubMed ID: 18819177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of heartburn and gastroesophageal reflux disease in the urban Brazilian population.
    Moraes-Filho JP; Chinzon D; Eisig JN; Hashimoto CL; Zaterka S
    Arq Gastroenterol; 2005; 42(2):122-7. PubMed ID: 16127569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey.
    MacGregor EA; Brandes J; Eikermann A
    Headache; 2003 Jan; 43(1):19-26. PubMed ID: 12864754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.
    Cady RK; Banks J; Jones BA; Campbell J
    Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD.
    de Bortoli N; Frazzoni L; Savarino EV; Frazzoni M; Martinucci I; Jania A; Tolone S; Scagliarini M; Bellini M; Marabotto E; Furnari M; Bodini G; Russo S; Bertani L; Natali V; Fuccio L; Savarino V; Blandizzi C; Marchi S
    Am J Gastroenterol; 2016 Dec; 111(12):1711-1717. PubMed ID: 27644732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population.
    Kotzan J; Wade W; Yu HH
    Pharm Res; 2001 Sep; 18(9):1367-72. PubMed ID: 11683254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of gastroesophageal reflux disease among hospital employees.
    Ercelep OB; Caglar E; Dobrucali A
    Dis Esophagus; 2014 Jul; 27(5):403-8. PubMed ID: 23020266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological study on the incidence of gastroesophageal reflux disease symptoms in patients in acute treatment with NSAIDs.
    Martín-de-Argila C; Martínez-Jiménez P
    Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):27-33. PubMed ID: 23265146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multicentre study "Epidemiology of gastroesophageal reflux disease in Russia"(MEGRE): first results].
    Lazebnik LB; Masharova AA; Bordin DS; Vasil'ev IuV; Tkachenko EI; Abdulkhakov RA; Butov MA; Eremina EIu; Zinchuk LI; Tsukanov VV
    Eksp Klin Gastroenterol; 2009; (6):4-12. PubMed ID: 20205320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Migraine Treatment.
    Becker WJ
    Continuum (Minneap Minn); 2015 Aug; 21(4 Headache):953-72. PubMed ID: 26252584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan.
    Fujiwara Y; Higuchi K; Watanabe Y; Shiba M; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Nishikawa H; Arakawa T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):26-9. PubMed ID: 15610442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastro-esophageal reflux disease in northwestern Tabriz, Iran.
    Khoshbaten M
    Indian J Gastroenterol; 2003; 22(4):138-9. PubMed ID: 12962436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of gastroesophageal reflux symptoms in Tehran, Iran: a population-based telephone survey.
    Nouraie M; Razjouyan H; Assady M; Malekzadeh R; Nasseri-Moghaddam S
    Arch Iran Med; 2007 Jul; 10(3):289-94. PubMed ID: 17604463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
    Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
    Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the prevalence of nighttime gastroesophageal reflux disease and disease severity.
    Dean BB; Aguilar D; Johnson LF; Fass R; Orr WC; McGuigan JE; Calimlim B; Yan N; Morgenstern D; Dubois RW
    Dig Dis Sci; 2010 Apr; 55(4):952-9. PubMed ID: 19693672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.